Subscribe to Newsletter

Other

Business & Profession Retina

Should Steroids Be Your First Port of Call in the Pseudophakic Eye?

| José Cunha-Vaz

Anti-VEGF agents are effective in treating DME – but not always indefinitely. Steroids work – but accelerate cataract development.

Business & Profession Other

The Ophthalmologist Innovation Awards 2014

Showcasing the greatest ophthalmic advances of the year

Business & Profession Retina

The Art Of Eyes

Popular culture has always viewed eyes as being things of beauty. But there’s more to the eye than the color of your irides.

Business & Profession Cornea / Ocular Surface

Acanthamoeba Ate my Eyeballs

| Roisin McGuigan

A student lost sight in one eye after failing to remove her disposable contact lenses for six months. So how did tabloid journalists turn it into such a popular news story?

Business & Profession Basic & Translational Research

The Curious Case of Sirtuins

| Roisin McGuigan

SIRT1 appears to be an anti-aging protein that protects against weight gain, diabetes, inflammation, and even optic neuritis… in mouse models. Is SIRT1 the key to eternal youth, or simply snake oil?

Business & Profession Other

Shortsighted Scholars

| Mark Hillen

Is the potential dystopia that is myopia a consequence of too much study?

Business & Profession Professional Development

Big Data in Medicine and Ophthalmology

| Pete Sudbury

Big data analytics is the most sophisticated method yet devised for “augmenting the human intellect”.

Business & Profession Other

The Uniqueness of Uveal Melanoma

| Takami Sato , Carol Shields

Uveal and skin melanoma originate in the same type of cell, but are very different in terms of molecular mechanism, pathobiology, prognosis and therapeutic strategy. Here, the features of uveal melanoma are described and the latest therapeutic developments discussed.

Business & Profession Professional Development

Regrets, I’ve Had a Few…

| Mark Hillen

If you had your time again, would you go to medical school, and would you choose ophthalmology?

Business & Profession Other

Don’t Disrespect Diamox

| Mark Hillen

Around since the 1950s, it has now been proven to improve visual outcomes in patients with idiopathic intracranial hypertension

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.